Page last updated: 2024-09-05

sb 203580 and Peripheral Nerve Injuries

sb 203580 has been researched along with Peripheral Nerve Injuries in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Chen, G; Chen, Y; Feng, F; Huang, S; Jia, Y; Su, W; Xue, P; Yang, T; Zhao, Y; Zhu, Z1
Cao, L; Malon, JT1

Other Studies

2 other study(ies) available for sb 203580 and Peripheral Nerve Injuries

ArticleYear
Delayed inhibition of ERK and p38 attenuates neuropathic pain without affecting motor function recovery after peripheral nerve injury.
    Neuropharmacology, 2022, 01-01, Volume: 202

    Topics: Animals; Axons; Butadienes; Disease Models, Animal; Enzyme Inhibitors; Extracellular Signal-Regulated MAP Kinases; Imidazoles; Male; Mice, Inbred C57BL; Nerve Regeneration; Neuralgia; Nitriles; p38 Mitogen-Activated Protein Kinases; Peripheral Nerve Injuries; Pyridines; Recovery of Function; Sciatic Nerve; Treatment Outcome

2022
Calcitonin gene-related peptide contributes to peripheral nerve injury-induced mechanical hypersensitivity through CCL5 and p38 pathways.
    Journal of neuroimmunology, 2016, 08-15, Volume: 297

    Topics: Animals; Antibodies; Calcitonin Gene-Related Peptide; Cells, Cultured; Chemokine CCL5; Cytokines; Disease Models, Animal; Enzyme Inhibitors; Female; Hyperalgesia; Imidazoles; Male; MAP Kinase Signaling System; Mice; Mice, Inbred BALB C; Neuroglia; Pain Threshold; Peptide Fragments; Peripheral Nerve Injuries; Pyridines; Spinal Cord; Spinal Nerves

2016